8-K current report · filed Oct 23, 2026

Arcosa, Inc. (ACA) 8-K Current Report: October 23, 2026

Item 1.02Item 3.01Item 5.01Item 5.02Item 5.03Item 3.03Item 2.01ACA overview

Short answer

Arcosa, Inc. (ACA) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement), Item 3.01 (Notice of Delisting), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 3.03 (Material Modification to Rights of Security Holders), Item 2.01 (Completion of Acquisition or Disposition of Assets). Merger closing terminated Arcosa’s $700 million revolving facility and $700 million term loan.

  • This filing includes Item 3.01, an item that often signal trouble.

Why these 8-K items matter →

Arcosa, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.02 · Termination of a Material Definitive Agreement

  • Merger closing terminated Arcosa’s $700 million revolving facility and $700 million term loan
  • Approximately $450.1 million of borrowings, accrued interest and other amounts repaid
  • Related guarantees and liens released, improving collateral flexibility after debt repayment
  • No material early termination fees or penalties incurred

Item 2.01 · Completion of Acquisition or Disposition of Assets

  • Arcosa completed its merger, converting outstanding common shares into $150.00 cash per share
  • Transaction consideration totaled approximately $7.5 billion, including common stock and cash-settled equity awards
  • Shares automatically canceled at closing, ending public equity ownership subject to appraisal rights
  • Outstanding unvested equity awards vested and converted to cash based on $150.00 per share plus unpaid dividend equivalents

Item 3.01 · Notice of Delisting

  • Merger completion triggered trading halt before October 23, 2026
  • Common stock delisted from NYSE and NYSE Texas
  • Form 25 filings requested to remove listing and deregister shares under Section 12(b)
  • Planned Form 15 filing would terminate registration and suspend SEC reporting obligations

Item 3.03 · Material Modification to Rights of Security Holders

  • Item 3.03 contains no standalone terms, instead incorporating the Introduction and Item 2.01 disclosures
  • Investor impact depends on the transaction details disclosed in Item 2.01, which determine any security-holder rights changes

Item 5.01 · Changes in Control of Registrant

  • Arcosa became wholly owned by Parent at merger closing, removing ACA from independent public-company ownership
  • Acquisition funding includes a $3.25 billion bridge facility and $2.5 billion term loan
  • Debt-funded transaction creates significant leverage and financing obligations at the combined company
  • J.P. Morgan SE serves as agent for both facilities

Item 5.02 · Departure/Election of Directors or Officers

  • Former Arcosa directors resigned upon merger completion
  • All pre-merger officers ceased serving in their roles
  • Departures tied to merger completion, not operational disagreements
  • Merger Sub directors and officers assumed Company leadership roles

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • Merger completed, with Arcosa’s governing documents replaced at the effective time
  • Arcosa retained its corporate name following the merger
  • Second amended charter and amended bylaws govern post-merger operations
  • Investors should review Exhibits 3.1 and 3.2 for changes affecting governance and shareholder rights

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Arcosa, Inc. 8-K filings

Get the next ACA 8-K as it lands

Follow ACA for push alerts, or ask the research agent what this filing means.